Company
Inspire Medical Systems, Inc.
Headquarters: Golden Valley, MN, United States
Employees: 485
CEO: Mr. Timothy P. Herbert
Market Cap
$3.79 Billion
USD as of July 1, 2025
Inspire Medical Systems, Inc. Categories
United States Healthcare Medical DevicesUnited States Healthcare United States Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $233.33 B |
| Boston Scientific Corporation | $154.34 B |
| Stryker | $151.06 B |
| Medtronic | $113.25 B |
| Edwards Lifesciences Corporation | $45.05 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Financials
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | $840.1 M |
| EBITDA | $81.0 M |
| Gross Profit TTM | $711.2 M |
| Profit Margin | 7.92% |
| Operating Margin | -0.74% |
| Quarterly Revenue Growth | 22.70% |
Stocks & Indices
Inspire Medical Systems, Inc. has the following listings and related stock indices.
Stock: NYSE: INSP wb_incandescent
Stock: FSX: 2DR wb_incandescent